| BDQ | Bedaquiline |
| CAP | Capreomycin |
| CFZ | Clofazimine |
| DLM | Delamanid |
| DR-TB | Drug-resistant tuberculosis |
| DST | Drug susceptibility tests |
| EMB | Ethambutol |
| ETH | Ethionamide |
| GenoType MTBDRplus | LPA GenoType MTBDRplus molecular method |
| Hr-TB | Isoniazid-resistant TB |
| INH | Isoniazid |
| KM | Kanamycin |
| L-J solid-medium | Löwenstein–Jensen solid-medium method () |
| LPA | Line probe assay |
| LVX | Levofloxacin |
| LZD | Linezolid |
| MDR-TB | Multidrug-resistant tuberculosis |
| MFX | Moxifloxacin |
| MGIT | BACTEC MGIT 960 |
| OFL | Ofloxacin |
| PCR | Polymerase Chain Reaction |
| pre-XDR-TB | Pre-extensive drug-resistant TB |
| RDR | Resistance Determining Region |
| RIF | Rifampicin |
| RR-TB | Rifampicin-resistant tuberculosis |
| STR | Streptomycin |
| TB | Tuberculosis |
| WGS | Whole genome sequencing |
| WHO | World Health Organization |
| XDR-TB | Extensively drug-resistant tuberculosis |